Lantern Pharma Inc (LTRN)
6.85
+0.70
(+11.38%)
USD |
NASDAQ |
May 06, 16:00
6.85
0.00 (0.00%)
After-Hours: 20:00
Lantern Pharma Net Income (TTM): -15.96M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -15.96M |
| September 30, 2023 | -15.16M |
| June 30, 2023 | -14.26M |
| March 31, 2023 | -14.01M |
| December 31, 2022 | -14.26M |
| September 30, 2022 | -14.42M |
| June 30, 2022 | -16.21M |
| March 31, 2022 | -14.03M |
| December 31, 2021 | -12.36M |
| Date | Value |
|---|---|
| September 30, 2021 | -11.72M |
| June 30, 2021 | -9.366M |
| March 31, 2021 | -7.883M |
| December 31, 2020 | -5.908M |
| September 30, 2020 | -3.687M |
| June 30, 2020 | -2.656M |
| March 31, 2020 | -2.452M |
| December 31, 2019 | -2.428M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-16.21M
Minimum
Jun 2022
-2.428M
Maximum
Dec 2019
-10.40M
Average
-12.36M
Median
Dec 2021
Net Income (TTM) Benchmarks
| Eyenovia Inc | -27.26M |
| Cassava Sciences Inc | -97.22M |
| Alpine Immune Sciences Inc | -32.18M |
| Clearside Biomedical Inc | -32.48M |
| Poseida Therapeutics Inc | -123.43M |